We have adjusted our estimates ahead of the 1Q24 trading update. The main effects are that we have increased our expected profitability for general insurance slightly to recognise the better margins at recently-acquired Probitas, and we deduct a debt instrument coming to call in 2024 and remove the associated interest costs. We do not consider the changes to be material; our rating is unchanged.